Chlormadinone acetate

Interesting facts

Interesting Facts About 17-acetyl-6-chloro-17-hydroxy-10,13-dimethyl-9,11,12,14,15,16-hexahydro-8H-cyclopenta[a]phenanthren-3-one

17-acetyl-6-chloro-17-hydroxy-10,13-dimethyl-9,11,12,14,15,16-hexahydro-8H-cyclopenta[a]phenanthren-3-one, often referred to in scientific circles due to its complexity, is a fascinating compound with intriguing characteristics and applications. Below are some interesting insights:

• Structure and Stability: The structure of this compound features a unique fusion of a cyclopenta[a]phenanthrene core. This intricate architecture contributes to its stability, which is essential for its biological activity.
• Biological Activity: Compounds similar to this one are often studied for their potential therapeutic benefits, particularly in oncology. Their ability to interact with biological pathways makes them candidates for cancer research.
• Chirality: This compound may possess chiral centers, which means it can exist in multiple forms that might exhibit different biological activities. Understanding chirality is crucial in the development of pharmaceuticals.
• Synthesis Strategies: The synthesis of such complex molecules involves advanced organic chemistry techniques. Researchers often employ methods such as functional group transformations and stereoselective synthesis to achieve the desired structure.
• Research Interest: Due to its complex nature, this compound is often a subject of study in medicinal chemistry and pharmacology, offering insights into drug design and discovery.
• Potential Applications: Aside from its potential role in cancer treatment, compounds of this nature can be explored for other medical applications, including anti-inflammatory and antimicrobial activities.

Overall, 17-acetyl-6-chloro-17-hydroxy-10,13-dimethyl-9,11,12,14,15,16-hexahydro-8H-cyclopenta[a]phenanthren-3-one exemplifies the complexity and beauty of organic chemistry, showcasing how intricate structures can lead to significant advancements in medicinal science.